SCHEMBL13985782

SCHEMBL13985782

O=C(OCCN(Cc1ccccc1)Cc1ccccc1)N1CCC(n2c(=O)n(CC3C=CC=CC3Cc3ccccc3)c3ccccc32)CC1

nearest known ligand 0.42

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ CACNA1G O43497 2/20 0.42
▸ CACNA1H O95180 2/20 0.42
▸ CYP3A4 P08684 9/20 0.40
▸ CYP2D6 P10635 7/20 0.40
▸ C5AR1 P21730 2/20 0.37
▸ ALDH1A1 P00352 1/20 0.36
▸ TACR1 P25103 1/20 0.36
▸ OPRM1 P35372 1/20 0.36
▸ CHRM2 P08172 1/20 0.35
▸ CHRM4 P08173 1/20 0.35
▸ CHRM5 P08912 1/20 0.35
▸ CHRM1 P11229 1/20 0.35
▸ CHRM3 P20309 1/20 0.35
▸ OPRL1 P41146 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13985802 0.85 OPRL1 (0.48) CACNA1GCACNA1HCYP3A4CYP2D6C5AR1
SCHEMBL13985723 0.81 CYP3A4 (0.48) CACNA1GCACNA1HCYP3A4CYP2D6C5AR1
SCHEMBL13985781 0.80 DRD2 (0.42) CACNA1GCACNA1HCYP3A4CYP2D6C5AR1
SCHEMBL13985629 0.79 ALDH1A1 (0.43) CACNA1GCACNA1HCYP3A4CYP2D6C5AR1
SCHEMBL13980436 0.78 CACNA1G (0.40) CACNA1GCACNA1HCYP3A4CYP2D6ALDH1A1
SCHEMBL13980457 0.78 JAK2 (0.44) CACNA1GCACNA1HALDH1A1OPRM1CHRM2
SCHEMBL13980393 0.78 CACNA1G (0.44) CACNA1GCACNA1HCYP3A4CYP2D6C5AR1
SCHEMBL13985721 0.77 ALDH1A1 (0.40) CACNA1GCACNA1HCYP3A4CYP2D6C5AR1
SCHEMBL13985630 0.77 ALDH1A1 (0.40) CACNA1GCACNA1HCYP3A4CYP2D6ALDH1A1
SCHEMBL13980481 0.75 CHRM1 (0.63) CYP3A4ALDH1A1OPRM1CHRM2CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008146172-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2008-12-04 — — WO disclosed
Send feedback